Menu
Last updated: 17/01/2022
Last reviewed: 17/01/2022
Below is a list of medications and their current associated recommendations regarding a third dose in the primary course of vaccination for COVID-19. An explanation of the difference between the primary course of vaccination and a booster dose can be found here.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: All forms of MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Secondary progressive MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS and primary progressive MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendations for a third dose in the primary course of vaccination: This medication is not expected to affect the immune response to vaccines and a third dose in the primary course of vaccination has not been recommended. A booster vaccination at the appropriate time after the 2-dose primary course of vaccination is recommended, currently 4 months afterwards.
Forms of MS used for: Relapsing remitting MS.
Recommendation for a third dose in the primary course of vaccination:Â This medication may affect the immune response to vaccines and a third dose in the primary course of vaccination is recommended by the Australian Technical Advisory Group on Immunisation (ATAGI). A booster vaccination at the appropriate time after the 3-dose primary course of vaccination is recommended, currently 4 months afterwards.
